Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...

Nerve damage is one of the most common and burdensome complications of diabetes. Millions of patients worldwide suffer from ...

Nerve damage is one of the most common and burdensome complications of diabetes. Millions of patients worldwide suffer from ...

In a previous mouse study, the same research team found a protein in the brain called Rap1, which impacted how glucose is ...

A University of Alberta team of researchers has discovered an additional 2 million Canadians who have a high fat diet or are overweight may be at increased risk for developing type 2 diabetes if they ...

The Best Pharmaceuticals for Children Act of 2002 mandated that the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) carries out critical reviews of the gaps in ...

HEALTH ALERT - U.S. government health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart ...

Pharmacology: Liraglutide is an analogue of human GLP-1 that acts as an agonist at GLP-1 receptors. Its properties differ from those of the native protein in that it has a longer half-life, enabling ...

Although there is one GLP-1 medication, Rybelsus, currently given as a daily pill, it has so far only been prescribed as a ...

PrandiMet stimulates release of insulin, improves insulin sensitivity, and decreases gluconeogenesis PrandiMet stimulates the release of insulin, improves insulin sensitivity, and decreases ...

A University of Alberta team of researchers has discovered an additional 2 million Canadians who have a high fat diet or are overweight may be at increased risk for developing type 2 diabetes if they ...